RASA1 and breast carcinoma: They further determined that miR-132-3p exerts its effects through RASA1, where the delivery of anti-miR-132-3p to vessel endothelium in an orthotopic xenograft mouse model of breast carcinoma restored RASA1 expression and suppressed angiogenesis [72].